Metraipolis › archive › dc_417c3f35bc90

Direct oral anticoagulant rivaroxaban for secondary prevention of catheter-related thrombosis in children with intestinal failure: real-life data — Europe PMC PMID:41311522

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41311522
DOI
10.1016/j.rpth.2025.103231
License (as archived)
solo-consultazione
Archived
2026-11-09T03:53:05.082Z
SHA-256 of the archived text
f366f3e8c4dc95043c29a044578594be43a082b868eeed753ded3f13aaafa6af
Stable URL of this page
https://metraipolis.com/documento/dc_417c3f35bc90

How to cite

Direct oral anticoagulant rivaroxaban for secondary prevention of catheter-related thrombosis in children with intestinal failure: real-life data — Europe PMC PMID:41311522 — Europe PMC (en), https://europepmc.org/article/MED/41311522 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_417c3f35bc90 (Metraipolis archive dc_417c3f35bc90, sha256 f366f3e8c4dc95043c29a044578594be43a082b868eeed753ded3f13aaafa6af)
BibTeX
@misc{dc417c3f35bc90,
  title = {Direct oral anticoagulant rivaroxaban for secondary prevention of catheter-related thrombosis in children with intestinal failure: real-life data — Europe PMC PMID:41311522},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41311522},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_417c3f35bc90; sha256 f366f3e8c4dc95043c29a044578594be43a082b868eeed753ded3f13aaafa6af},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41311522. Agents can read the archived copy with the MCP tool read_document.